| The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy B Muz, P de la Puente, F Azab, A Kareem Azab Hypoxia, 83-92, 2015 | 1885 | 2015 |
| BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression AM Roccaro, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, ... The Journal of clinical investigation 123 (4), 1542-1555, 2013 | 835 | 2013 |
| CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy AK Azab, JM Runnels, C Pitsillides, AS Moreau, F Azab, X Leleu, X Jia, ... Blood, The Journal of the American Society of Hematology 113 (18), 4341-4351, 2009 | 483 | 2009 |
| MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma AM Roccaro, A Sacco, B Thompson, X Leleu, AK Azab, F Azab, J Runnels, ... Blood, The Journal of the American Society of Hematology 113 (26), 6669-6680, 2009 | 389 | 2009 |
| Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features AK Azab, J Hu, P Quang, F Azab, C Pitsillides, R Awwad, B Thompson, ... Blood, The Journal of the American Society of Hematology 119 (24), 5782-5794, 2012 | 349 | 2012 |
| LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas Y Zhang, AM Roccaro, C Rombaoa, L Flores, S Obad, SM Fernandes, ... Blood, The Journal of the American Society of Hematology 120 (8), 1678-1686, 2012 | 181 | 2012 |
| Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion P Neri, L Ren, AK Azab, M Brentnall, K Gratton, AC Klimowicz, C Lin, ... Blood, The Journal of the American Society of Hematology 117 (23), 6202-6213, 2011 | 168 | 2011 |
| Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma S Blotta, J Jakubikova, T Calimeri, AM Roccaro, N Amodio, AK Azab, ... Blood, The Journal of the American Society of Hematology 120 (25), 5002-5013, 2012 | 153 | 2012 |
| SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia HT Ngo, X Leleu, J Lee, X Jia, M Melhem, J Runnels, AS Moreau, ... Blood, The Journal of the American Society of Hematology 112 (1), 150-158, 2008 | 151 | 2008 |
| Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib E Weisberg, AK Azab, PW Manley, AL Kung, AL Christie, R Bronson, ... Leukemia 26 (5), 985-990, 2012 | 147 | 2012 |
| Spotlight on ixazomib: potential in the treatment of multiple myeloma B Muz, RN Ghazarian, M Ou, MJ Luderer, HD Kusdono, AK Azab Drug design, development and therapy, 217-226, 2016 | 143 | 2016 |
| Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia IM Ghobrial, A Roccaro, F Hong, E Weller, N Rubin, R Leduc, M Rourke, ... Clinical Cancer Research 16 (3), 1033-1041, 2010 | 142 | 2010 |
| microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia AM Roccaro, A Sacco, C Chen, J Runnels, X Leleu, F Azab, AK Azab, ... Blood, The Journal of the American Society of Hematology 113 (18), 4391-4402, 2009 | 141 | 2009 |
| 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma P de la Puente, B Muz, RC Gilson, F Azab, M Luderer, J King, S Achilefu, ... Biomaterials 73, 70-84, 2015 | 140 | 2015 |
| RhoA and Rac1 GTPases play major and differential roles in stromal cell–derived factor-1–induced cell adhesion and chemotaxis in multiple myeloma AK Azab, F Azab, S Blotta, CM Pitsillides, B Thompson, JM Runnels, ... Blood, The Journal of the American Society of Hematology 114 (3), 619-629, 2009 | 139 | 2009 |
| Targeting NF-κB in Waldenstrom macroglobulinemia X Leleu, J Eeckhoute, X Jia, AM Roccaro, AS Moreau, M Farag, A Sacco, ... Blood, The Journal of the American Society of Hematology 111 (10), 5068-5077, 2008 | 138 | 2008 |
| microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia AM Roccaro, A Sacco, X Jia, AK Azab, P Maiso, HT Ngo, F Azab, ... Blood, The Journal of the American Society of Hematology 116 (9), 1506-1514, 2010 | 136 | 2010 |
| P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment AK Azab, P Quang, F Azab, C Pitsillides, B Thompson, T Chonghaile, ... Blood, The Journal of the American Society of Hematology 119 (6), 1468-1478, 2012 | 130 | 2012 |
| Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia AM Roccaro, A Sacco, EN Husu, C Pitsillides, S Vesole, AK Azab, F Azab, ... Blood, The Journal of the American Society of Hematology 115 (3), 559-569, 2010 | 125 | 2010 |
| Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat AK Azab, V Doviner, B Orkin, J Kleinstern, M Srebnik, A Nissan, ... Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2007 | 124 | 2007 |
Irene GhobrialDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
